Compare CRTO & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRTO | SDGR |
|---|---|---|
| Founded | 2005 | 1990 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.9M | 925.8M |
| IPO Year | 2013 | 2020 |
| Metric | CRTO | SDGR |
|---|---|---|
| Price | $17.31 | $13.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $34.00 | $21.00 |
| AVG Volume (30 Days) | 324.6K | ★ 1.3M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.95 | ★ 45.14 |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $2,296,692,000.00 | $255,869,000.00 |
| Revenue This Year | N/A | $0.76 |
| Revenue Next Year | $5.54 | $4.60 |
| P/E Ratio | $114.33 | ★ N/A |
| Revenue Growth | ★ 27.65 | 23.29 |
| 52 Week Low | $15.58 | $10.95 |
| 52 Week High | $27.48 | $27.63 |
| Indicator | CRTO | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 61.15 |
| Support Level | $16.14 | $11.18 |
| Resistance Level | $20.16 | $13.36 |
| Average True Range (ATR) | 0.82 | 0.66 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 36.73 | 85.17 |
Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.